Symbiotec Pharmalab IPO Allotment Status

Listed RegistrarMUFG Intime India Pvt. Ltd. Allotment28 Aug 2026 Listed at₹988.00 +0.00%

Check Symbiotec Pharmalab Allotment Status by PAN

Enter the PAN you applied with — the result comes straight from MUFG Intime India Pvt. Ltd..

10 characters: 5 letters, 4 digits, 1 letter

Not getting a result here? You can also check Symbiotec Pharmalab allotment directly on the Link Intime / MUFG portal →

Check every IPO in one tap

  1. 1Sign in with Google — no password, free
  2. 2Save your PAN — and your family's, up to 5
  3. 3Check any IPO — all saved PANs at once
Continue with Google

🔒 PANs are shown masked and can be removed anytime.

Symbiotec Pharmalab IPO — Allotment & Listing Timeline

  1. IPO Open 24 Aug 2026
  2. IPO Close 27 Aug 2026
  3. Basis of Allotment 28 Aug 2026
  4. Refund Initiation 31 Aug 2026
  5. Listing Date 01 Sept 2026
Issue Price₹938–988
Lot Size15 shares
Issue Size₹1,757.00 Cr
IPO TypeMainboard
Listing AtBoth
RegistrarMUFG Intime India Pvt. Ltd.
Listing Price₹988.00
Listing Gain+0.00%

Symbiotec Pharmalab IPO — Subscription & Allotment Odds

Based on the latest subscription figures for Symbiotec Pharmalab IPO (overall 75.05x subscribed). The more a category is oversubscribed, the lower each applicant's chance of allotment.

Retail 8.4% (13.64x)
Low chance
S-HNI 1.7% (58.00x)
Low chance
B-HNI 5.7% (87.34x)
Low chance
Employee 6.1% (16.31x)
Low chance

In the Retail category, about 8 in 100 applicants would get an allotment in Symbiotec Pharmalab IPO. Winners are picked by draw of lots and each gets 15 shares (one lot), so applying for more than the minimum does not improve retail odds.

How Many Symbiotec Pharmalab Retail Applicants Get Shares

Retail shares reserved62,13,562
Minimum application15 shares · ₹14,820
Retail winners (max)4,14,237
Retail applications (est.)~49,56,309

Symbiotec Pharmalab set aside 62,13,562 shares for retail investors. Each successful applicant receives 15 shares (one lot), so the retail quota can serve at most 4,14,237 applicants. With retail subscribed 13.64x, that points to roughly 49,56,309 retail applications competing for those allotments.

Estimate from the prospectus reservation and the final subscription; the registrar's Basis of Allotment has the exact count.

Symbiotec Pharmalab IPO Subscription, Day by Day

Times subscribed at the close of each bidding day.

DayRetailNII QIB Total
Day 1 1.00x 1.10x 0.37x 0.85x
Day 2 2.21x 3.16x 0.57x 1.95x
Day 3 5.32x 12.83x 0.62x 5.59x
Day 4 13.64x 77.56x 181.20x 75.05x

Retail demand grew from 1.00x on day 1 to 13.64x by day 4 — 13.6x over the bidding window.

Symbiotec Pharmalab Retail Odds vs Earlier Mainboard IPOs

At about 8.4%, the estimated retail odds for Symbiotec Pharmalab were lower than 5 of the 10 mainboard IPOs before it.

Median across those 10 issues: 6.4%. Best odds: Horizon Industrial Parks (100.0%, retail 1.01x); lowest: Tempsens Instruments (1.9%, retail 60.40x).

What Symbiotec Pharmalab Allottees Made on Listing Day

Issue price₹988.00
Listing price₹988.00
Per minimum application+₹0
Last GMP before listing₹200

Symbiotec Pharmalab listed at ₹988.00 (+0.00% on the issue price). An applicant allotted 15 shares (one lot) broke even at the listing price, before charges. The last grey market premium we recorded (₹200 on 31 Aug) pointed to about ₹1,188; the actual listing was ₹200 lower.

Checking Symbiotec Pharmalab Allotment

Enter the PAN you applied with in the box above; the check goes to MUFG Intime India Pvt. Ltd., the registrar for Symbiotec Pharmalab IPO, which finalised the allotment on 28 Aug 2026.

How the draw of lots works is the same for every issue — see IPO Allotment Process Explained. See all recent IPO allotment results. Last updated: 28 Aug 2026, 10:26 pm IST.

Symbiotec Pharmalab Allotment FAQs

The registrar for Symbiotec Pharmalab IPO is MUFG Intime India Pvt. Ltd., which finalised the allotment on 28 Aug 2026.

The Symbiotec Pharmalab IPO allotment date was 28 Aug 2026; the issue closed on 27 Aug 2026.

The amount blocked through your ASBA / UPI mandate is released within 1-2 working days of the 28 Aug 2026 allotment; the refund date for Symbiotec Pharmalab was 31 Aug 2026. With retail subscribed 13.64x, roughly 92% of retail applicants were expected to miss out.

Symbiotec Pharmalab lists on 01 Sept 2026; allotted shares are credited one working day earlier, on or just before 31 Aug 2026.

Symbiotec Pharmalab was subscribed 75.05x overall. Oversubscribed categories are allotted by draw of lots, each winner getting the minimum application, which in retail is 15 shares (one lot). Estimated odds: Retail 13.64x, about 8.4%; S-HNI 58.00x, about 1.7%; B-HNI 87.34x, about 5.6%; Employee 16.31x, about 6.1%. QIB is allotted proportionately, not by lottery.
GMPUpdate